Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Dental Products Panel

This article was originally published in The Gray Sheet

Executive Summary

Dental Products Panel: Review of a premarket approval application for a bone filling/augmentation device is on the agenda for a Jan. 12 meeting at FDA's Corporate Building in Rockville, Maryland. On Jan. 13, the panel will focus on the appropriate classification of the following endosseous implant subgroups: coated and uncoated root form implants, coated and uncoated blade-type implants, temporary implants, and implants with special enhanced features. Written submissions are due at the agency by Dec. 29; for more information contact FDA's Pamela Scott at 301/827-5283...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009293

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel